Skip to content
Lower risk Drug recall · FDA · Published December 15, 2023

Dr. Reddy's Tacrolimus Capsules 1mg Recall: Foreign Tablets Found

Dr. Reddy's recalls 100-count Tacrolimus capsules (1mg) due to foreign tablets found in some bottles. This is a medication for immunosuppression.

🇺🇸 FDA recall #D-0219-2024DrugDr. Reddy's ›
Take action

Contact the company

Recalling firmDr. Reddy's Laboratories, Inc.107 College Rd E · Princeton, NJ 08540-6623
✎ GovInfoNow plain-language explainer

Dr. Reddy's is recalling 100-count Tacrolimus capsules (1mg) because foreign tablets were found in some bottles. This could lead to incorrect dosing if taken without knowing the actual contents. Read more at govinfonow.com/recall/32924-dr-reddy-s-tacrolimus-capsules-1mg-recall-foreign-tablets-found.

Source Summary by GovInfoNow · govinfonow.com/recall/32924-dr-reddy-s-tacrolimus-capsules-1mg-recall-foreign-tablets-found · Updated August 17, 2026 · FDA enforcement record: FDA #D-0219-2024

Cite this page

“Dr. Reddy's Tacrolimus Capsules 1mg Recall: Foreign Tablets Found.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32924-dr-reddy-s-tacrolimus-capsules-1mg-recall-foreign-tablets-found. Based on FDA recall #D-0219-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0219-2024%22&limit=1).

Dr. Reddy's Laboratories, Inc. recalled Tacrolimus Capsels USP 1mg on Dec. 15, 2023, after the FDA announced the presence of foreign tablets in some bottles, according to FDA records.

How to tell if you have it

  • Brand: Dr. Reddy's
  • Product: Tacrolimus Capsules, USP 1mg, 100-Count Bottles
  • NDC: 55111-526-01
  • Lot#: C2307275
  • Expiration: January 2026

The hazard

The recall addresses the presence of foreign tablets or capsules, specifically one 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.

Context

GovInfoNow's records show Dr. Reddy's Laboratories, Inc. has 85 other recalls on record since April 9, 2012. Other recent recalls of similar products include Dr. Reddy's Varenicline Tablets Recall (Nov. 11, 2025), Dr. Reddy's Succinylcholine Chloride Injection Recall (Sept. 26, 2025), and Dr. Reddy's Omeprazole Capsules Recall (June 30, 2025). Other recent recalls of similar products include Granules Pharmaceuticals Trazodone 50mg Recall (Jan. 26, 2026), Golden State Baclofen Tablets Recall (Nov. 26, 2025), and Annora Pharma Pitavastatin Tablets 2mg Recall (Feb. 3, 2026).

How to tell if you have this one

Check for the NDC number 55111-526-01 and lot number C2307275 on the bottle. The capsules are for prescription use only and expire in January 2026.

  • Brand
    Dr. Reddy's
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Capsule Contents

    Inspect the bottle for foreign tablets inside the 1mg capsules. If found, do not use the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Dec 15, 202312. FDA classified it Class II: Jan 5, 202423. Published in FDA’s Enforcement Report: Jan 17, 202434. FDA terminated the recall: Sep 16, 2024420232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Dr. Reddy's recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0219-2024 (December 15, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0219-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA